Status: current, Defined. Date: 28-Feb 2010. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
465012011000036113 | Maxalt (rizatriptan 10 mg) wafer (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
465013011000036118 | Maxalt 10 mg wafer | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Maxalt 10 mg wafer | has manufactured dose form | wafer | true | Inferred relationship | Some | ||
Maxalt 10 mg wafer | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Maxalt 10 mg wafer | Is a | Maxalt | true | Inferred relationship | Some | ||
Maxalt 10 mg wafer | Is a | rizatriptan 10 mg wafer | true | Inferred relationship | Some | ||
Maxalt 10 mg wafer | has unit of use | wafer | true | Inferred relationship | Some | 1081461265 | |
Maxalt 10 mg wafer | has intended active ingredient | rizatriptan | true | Inferred relationship | Some | 1081461264 | |
Maxalt 10 mg wafer | has Australian BoSS | rizatriptan | true | Inferred relationship | Some | 1081461264 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Maxalt 10 mg wafer, 2 | has TPUU | True | Maxalt 10 mg wafer | Inferred relationship | Some | 1 |
Maxalt 10 mg wafer, 2, blister pack | has TPUU | True | Maxalt 10 mg wafer | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Trade product unit of use reference set